Stock Track | Tandem Diabetes Care Plummets 5.51% as Citi Downgrades Stock

Stock Track
2025/03/04

Shares of Tandem Diabetes Care (TNDM) plummeted 5.51% in intraday trading on Tuesday, underperforming the broader market. The sell-off came after Citi analyst Joanne Wuensch downgraded the stock to Neutral from Buy.

Wuensch also slashed her price target on TNDM to $24, down from the previous target of $35. The analyst's move to downgrade and lower the price target suggests concerns over the company's prospects and growth outlook.

The downgrade by the influential Wall Street firm has led to increased selling pressure on Tandem Diabetes Care's shares. Investors are likely reassessing their positions and expectations for the medical device company following Citi's bearish stance.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10